MX383746B - Solución de isoxazolina que contiene vitamina e para usarse con agua potable desinfectada. - Google Patents
Solución de isoxazolina que contiene vitamina e para usarse con agua potable desinfectada.Info
- Publication number
- MX383746B MX383746B MX2017016671A MX2017016671A MX383746B MX 383746 B MX383746 B MX 383746B MX 2017016671 A MX2017016671 A MX 2017016671A MX 2017016671 A MX2017016671 A MX 2017016671A MX 383746 B MX383746 B MX 383746B
- Authority
- MX
- Mexico
- Prior art keywords
- drinking water
- isoxazoline
- solution containing
- vitamin
- containing vitamin
- Prior art date
Links
- WEQPBCSPRXFQQS-UHFFFAOYSA-N 4,5-dihydro-1,2-oxazole Chemical compound C1CC=NO1 WEQPBCSPRXFQQS-UHFFFAOYSA-N 0.000 title abstract 5
- 239000003651 drinking water Substances 0.000 title abstract 5
- 235000020188 drinking water Nutrition 0.000 title abstract 5
- 229940088594 vitamin Drugs 0.000 title 1
- 229930003231 vitamin Natural products 0.000 title 1
- 235000013343 vitamin Nutrition 0.000 title 1
- 239000011782 vitamin Substances 0.000 title 1
- 150000003722 vitamin derivatives Chemical class 0.000 title 1
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 abstract 4
- 241001465754 Metazoa Species 0.000 abstract 3
- 206010061217 Infestation Diseases 0.000 abstract 2
- 229930003427 Vitamin E Natural products 0.000 abstract 2
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 abstract 2
- WQYVRQLZKVEZGA-UHFFFAOYSA-N hypochlorite Chemical compound Cl[O-] WQYVRQLZKVEZGA-UHFFFAOYSA-N 0.000 abstract 2
- 244000045947 parasite Species 0.000 abstract 2
- 238000011012 sanitization Methods 0.000 abstract 2
- 229940046009 vitamin E Drugs 0.000 abstract 2
- 235000019165 vitamin E Nutrition 0.000 abstract 2
- 239000011709 vitamin E Substances 0.000 abstract 2
- 230000002141 anti-parasite Effects 0.000 abstract 1
- 239000003096 antiparasitic agent Substances 0.000 abstract 1
- 230000015556 catabolic process Effects 0.000 abstract 1
- 239000006184 cosolvent Substances 0.000 abstract 1
- 238000006731 degradation reaction Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 239000002904 solvent Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
- A61K31/355—Tocopherols, e.g. vitamin E
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A61K31/422—Oxazoles not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Tropical Medicine & Parasitology (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- General Physics & Mathematics (AREA)
- Physics & Mathematics (AREA)
- Fodder In General (AREA)
- Mechanical Engineering (AREA)
- Ceramic Engineering (AREA)
- Food Science & Technology (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Immunology (AREA)
- Pathology (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP15173454 | 2015-06-23 | ||
| PCT/EP2016/064449 WO2016207234A1 (en) | 2015-06-23 | 2016-06-22 | Isoxazoline solution containing vitamin e for use with sanitized drinking water |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MX2017016671A MX2017016671A (es) | 2018-03-15 |
| MX383746B true MX383746B (es) | 2025-03-14 |
Family
ID=53488226
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2017016671A MX383746B (es) | 2015-06-23 | 2016-06-22 | Solución de isoxazolina que contiene vitamina e para usarse con agua potable desinfectada. |
Country Status (10)
| Country | Link |
|---|---|
| US (3) | US20180169073A1 (enExample) |
| EP (1) | EP3313400B1 (enExample) |
| JP (1) | JP6933983B2 (enExample) |
| CN (1) | CN107750159B (enExample) |
| BR (1) | BR112017027855B1 (enExample) |
| ES (1) | ES2920394T3 (enExample) |
| HU (1) | HUE059228T2 (enExample) |
| MX (1) | MX383746B (enExample) |
| PL (1) | PL3313400T3 (enExample) |
| WO (1) | WO2016207234A1 (enExample) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20170232024A1 (en) | 2014-08-04 | 2017-08-17 | Jerry Tan Eye Surgery Pte Ltd | Pharmaceutical compositions for demodex related blepharitis and eyelid crusting |
| KR102668200B1 (ko) * | 2015-10-28 | 2024-05-23 | 주식회사유한양행 | 지속형 fgf21 융합 단백질 및 이를 포함하는 약학적 조성물 |
| UY37137A (es) | 2016-02-24 | 2017-09-29 | Merial Inc | Compuestos antiparasitarios de isoxazolina, formulaciones inyectables de acción prolongada que los comprenden, métodos y usos de los mismos |
| CN119157876A (zh) | 2017-12-15 | 2024-12-20 | 塔苏斯制药有限公司 | 用于治疗睑炎的异恶唑啉驱虫剂制剂和方法 |
| US12502377B2 (en) | 2019-04-04 | 2025-12-23 | Tarsus Pharmaceuticals, Inc. | Method of eradicating ticks that attach to humans using lotilaner formulations |
| MX2022007455A (es) | 2019-12-18 | 2022-08-15 | Elanco Tiergesundheit Ag | Derivados de isoxazolina como plaguicidas. |
| JP7724845B2 (ja) | 2020-07-24 | 2025-08-18 | エランコ・ユーエス・インコーポレイテッド | イソオキサゾリン化合物及びその中間体を作製するための方法 |
| KR20230061465A (ko) | 2020-09-04 | 2023-05-08 | 엘랑코 유에스 인코포레이티드 | 기호성 제형 |
| CA3211576A1 (en) * | 2021-03-11 | 2022-09-15 | In The Bowl Animal Health, Inc. | Oral canine feed and methods for controlling tick infestations in a canine |
| CN114306231B (zh) * | 2021-12-29 | 2023-03-24 | 天津市中升挑战生物科技有限公司 | 一种氟雷拉纳杀虫剂及其制备方法和应用 |
| CN115266988A (zh) * | 2022-08-01 | 2022-11-01 | 江苏慧聚药业股份有限公司 | 一种氟雷拉钠有关物质的检测方法 |
| CN117064851B (zh) * | 2023-09-20 | 2026-02-17 | 中国农业大学 | 一种异噁唑啉类驱虫药制剂的制备方法 |
| CN118477040B (zh) * | 2024-04-11 | 2025-02-25 | 河北威远药业有限公司 | 一种氟雷拉纳溶液的制备方法 |
Family Cites Families (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5962488A (en) * | 1998-04-08 | 1999-10-05 | Roberts Laboratories, Inc. | Stable pharmaceutical formulations for treating internal bowel syndrome containing isoxazole derivatives |
| ATE473944T1 (de) * | 2000-06-27 | 2010-07-15 | Procter & Gamble | Mittel zur wasserbehandlung |
| US20050005868A1 (en) * | 2003-07-11 | 2005-01-13 | Shepard Allan T. | Animal drinking water production |
| CN101768129B (zh) | 2004-03-05 | 2012-05-23 | 日产化学工业株式会社 | 异*唑啉取代苯甲酰胺化合物的制备中间体 |
| TWI412322B (zh) | 2005-12-30 | 2013-10-21 | Du Pont | 控制無脊椎害蟲之異唑啉 |
| JP2007319124A (ja) * | 2006-06-02 | 2007-12-13 | Nippon Tablet Kk | 健康食品 |
| RU2009141185A (ru) | 2007-04-10 | 2011-05-20 | Байер КропСайенс АГ (DE) | Инсектицидные производные арилизоксазолина |
| TWI430995B (zh) | 2007-06-26 | 2014-03-21 | Du Pont | 萘異唑啉無脊椎有害動物控制劑 |
| HUE037127T2 (hu) | 2007-06-27 | 2018-08-28 | Du Pont | Állati károkozó irtására szolgáló eljárás |
| US20090024541A1 (en) * | 2007-07-20 | 2009-01-22 | Gary Kremen | Power purchase methods, agreements and financial instruments for tax-advantaged financing residential renewable energy equipment |
| TWI556741B (zh) * | 2007-08-17 | 2016-11-11 | 英特威特國際股份有限公司 | 異唑啉組成物及其作為抗寄生蟲藥上的應用 |
| TWI411395B (zh) | 2007-12-24 | 2013-10-11 | Syngenta Participations Ag | 殺蟲化合物 |
| WO2010003923A1 (en) * | 2008-07-09 | 2010-01-14 | Basf Se | Pestcidal active mixtures comprising isoxazoline compounds i |
| US7951404B2 (en) | 2008-07-11 | 2011-05-31 | Sanosil Ag | Concentrate for preparing a disinfectant and methods for its preparation and use |
| EP2379544B1 (en) | 2008-12-18 | 2013-10-16 | Novartis AG | Isoxazolines derivatives and their use as pesticide |
| PL2379537T3 (pl) | 2008-12-19 | 2013-03-29 | Elanco Tiergesundheit Ag | Pochodne izooksazoliny i ich zastosowanie jako pestycydów |
| ME02432B (me) | 2009-12-17 | 2016-09-20 | Merial Inc | Antiparazitska jedinjenja dihidroazola i kompozicije koje ih sadrže |
| EP2531493B1 (en) * | 2010-02-01 | 2015-07-22 | Basf Se | Substituted ketonic isoxazoline compounds and derivatives for combating animal pests |
| WO2011124998A1 (en) | 2010-04-08 | 2011-10-13 | Pfizer Inc. | Substituted 3,5- di phenyl - isoxazoline derivatives as insecticides and acaricides |
| WO2012155352A1 (en) | 2011-05-19 | 2012-11-22 | Eli Lilly And Company | Dihydroisoxazole compounds, parasiticidal uses and formulations thereof |
| WO2013026695A1 (en) | 2011-08-25 | 2013-02-28 | Syngenta Participations Ag | Isoxazoline derivatives as insecticidal compounds |
| CN103764644A (zh) | 2011-08-25 | 2014-04-30 | 先正达参股股份有限公司 | 作为杀虫化合物的异噁唑啉衍生物 |
| PT3172964T (pt) * | 2011-09-12 | 2020-11-30 | Boehringer Ingelheim Animal Health Usa Inc | Composições parasiticidas compreendendo um agente ativo de isoxazolina, método e utilizações das mesmas |
| EP3052080B1 (en) | 2013-09-30 | 2025-06-25 | Zoetis Services LLC | Long-acting spiro-isoxazoline formulations |
| US9371293B2 (en) | 2013-10-25 | 2016-06-21 | Sumitomo Chemical Company, Limited | Isoxazoline compound composition |
| CN105873925B (zh) | 2013-11-01 | 2019-09-10 | 勃林格殷格翰动物保健美国公司 | 抗寄生物的和杀虫的异噁唑啉化合物 |
| CN105992517B (zh) * | 2013-12-10 | 2020-03-06 | 英特维特国际股份有限公司 | 异噁唑啉化合物的抗寄生虫用途 |
| JP6581586B2 (ja) * | 2013-12-20 | 2019-09-25 | インターベット インターナショナル ベー． フェー． | イソオキサゾリン組成物および動物における寄生虫侵襲の予防または処置におけるその使用 |
| RU2688167C1 (ru) * | 2013-12-20 | 2019-05-20 | Интервет Интернэшнл Б.В. | Применение изоксазолиновых соединений на домашней птице |
| CA2965524C (en) * | 2014-11-03 | 2020-04-14 | Zoetis Services Llc | Palatable chewable veterinary composition |
-
2016
- 2016-06-22 CN CN201680036814.8A patent/CN107750159B/zh active Active
- 2016-06-22 PL PL16733385.5T patent/PL3313400T3/pl unknown
- 2016-06-22 HU HUE16733385A patent/HUE059228T2/hu unknown
- 2016-06-22 EP EP16733385.5A patent/EP3313400B1/en active Active
- 2016-06-22 JP JP2017566402A patent/JP6933983B2/ja active Active
- 2016-06-22 ES ES16733385T patent/ES2920394T3/es active Active
- 2016-06-22 BR BR112017027855-3A patent/BR112017027855B1/pt active IP Right Grant
- 2016-06-22 MX MX2017016671A patent/MX383746B/es unknown
- 2016-06-22 US US15/735,252 patent/US20180169073A1/en not_active Abandoned
- 2016-06-22 WO PCT/EP2016/064449 patent/WO2016207234A1/en not_active Ceased
-
2019
- 2019-07-26 US US16/523,780 patent/US11179372B2/en active Active
-
2021
- 2021-07-30 US US17/390,258 patent/US11878006B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| US20210354283A1 (en) | 2021-11-18 |
| BR112017027855A2 (enExample) | 2018-08-21 |
| MX2017016671A (es) | 2018-03-15 |
| BR112017027855B1 (pt) | 2022-11-16 |
| CN107750159B (zh) | 2021-10-29 |
| PL3313400T3 (pl) | 2022-07-25 |
| US11878006B2 (en) | 2024-01-23 |
| WO2016207234A1 (en) | 2016-12-29 |
| EP3313400B1 (en) | 2022-06-15 |
| JP2018521995A (ja) | 2018-08-09 |
| US20180169073A1 (en) | 2018-06-21 |
| ES2920394T3 (es) | 2022-08-03 |
| JP6933983B2 (ja) | 2021-09-08 |
| EP3313400A1 (en) | 2018-05-02 |
| US20190343808A1 (en) | 2019-11-14 |
| US11179372B2 (en) | 2021-11-23 |
| HUE059228T2 (hu) | 2022-10-28 |
| CN107750159A (zh) | 2018-03-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2017016671A (es) | Solucion de isoxazolina que contiene vitamina e para usarse con agua potable desinfectada. | |
| MX2016008118A (es) | Composiciones de isoxazolina y uso de las mismas en la prevencion o tratamiento de infestaciones parasitarias en animales. | |
| CL2017002164A1 (es) | Formulaciones inyectables de acción prolongada que comprenden un agente activo isoxazolina, métodos y usos de las mismas | |
| MX373444B (es) | Compuestos organicos de monobactam para el tratamiento de infecciones bacterianas. | |
| MD4577B1 (ro) | Compoziţii masticabile de uz veterinar care conţin agent activ izoxazolinic şi utilizarea acestora în tratamentul sau prevenirea unei infestări sau infecţii parazitare | |
| MX376210B (es) | Uso de derivados de isoxazolina para el tratamiento o prevención de infestaciones por artrópodos en aves de corral. | |
| CL2015002744A1 (es) | Alimento para peces que comprende azadiractina, útil para el tratamiento y/o prevención de infecciones y/o infestaciones parasitarias, particularmente contra el piojo de mar lepeophtherius salmonis. | |
| MX2017003205A (es) | Composiciones antimicrobianas y sus metodos de uso. | |
| CL2015002319A1 (es) | Dispositivo y sistema para el tratamiento de peces. | |
| CL2017000178A1 (es) | Compuestos para usar en el tratamiento antihelmíntico | |
| EP3732968A4 (en) | ANTIMICROBIAL WITH HYPOCHLOROIC ACID | |
| MX2017002818A (es) | Composiciones topicas de pterostilbeno para utilizarse en el tratamiento de la perdida inducida por uv de la funcion de barrera en la piel. | |
| MX2017004899A (es) | Compuestos derivado de pirazolina y su uso en una pauta posológica semanal contra la inflamación y el dolor derivados de la enfermedad articular degenerativa en mamíferos. | |
| UY36389A (es) | Composiciones y usos de las mismas para el tratamiento de ulceras y sintomas relacionados en animales no humanos | |
| MX380385B (es) | Agente para el tratamiento de infeccion respiratoria. | |
| MX2016011572A (es) | Composiciones antimicrobianas de acido organico. | |
| CL2016003273A1 (es) | Composiciones antimicrobianas con agentes efervescentes | |
| CL2018002422A1 (es) | Preparación que contiene agua de mar a la que se ha agregado un compuesto de potasio. | |
| FR3019047B1 (fr) | Diffuseur d'agent parfumant et/ou assainissant active par retournement. | |
| CL2012002768A1 (es) | Solucion antiseptica para prevencion de mastitis subclinica en vacas lecheras que comprende una mezcla de propoleo y solucion de miel de abejas en proporciones desde 1:5 a 5:1, uso de la solucion antiseptica porque sirve para la profilaxis, prevencion y control de mastitis subclinica de vacas lecheras. | |
| ES2388268B1 (es) | Comprimidos para el tratamiento y desinfeccion de aguas que contienen un derivado halogenado y un lubricante | |
| CL2016003271A1 (es) | Métodos para tratar infecciones | |
| AR109209A1 (es) | Composición farmacéutica para prevención o tratamiento de enfermedades neurodegenerativas | |
| EA201300351A1 (ru) | Инъекционная ветеринарная композиция в виде раствора для борьбы с полиинвазиями животного и способ ее получения | |
| CL2019001260A1 (es) | Formulaciones antimicrobianas para el tratamiento mejorado de infecciones veterinarias de pezuña |